Interactive Brokers Advertisement
Home > Boards > US OTC > Biotechs >

PharmaCyte Biotech Inc. (PMCB)

Add PMCB Price Alert      Hide Sticky   Hide Intro
Moderator: mick, Peacefulwendy, $Pistol Pete$, thenewmixer, fraum, concordia
Search This Board: 
Last Post: 11/24/2017 6:59:44 PM - Followers: 780 - Board type: Free - Posts Today: 9

Welcome to PharmaCyte BioTech
An OTCQB Company

PharmaCyte is a clinical stage biotechnology company developing therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as "Cell-in-a-Box." This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed. For cancer, the therapy involves encapsulating genetically engineered human cells that convert the prodrug ifosfamide from its inactive form to its "cancer" killing form. These encapsulated live cells are implanted in a patient as close to the tumor as possible. Then ifosfamide is given IV at one-third the normal dose. When the ifosfamide comes in contact with the encapsulated live cells, they act as an artificial liver (where ifosfamide is normally activated) and activate the ifosfamide at the source of the cancer. For diabetes, PharmaCyte is developing a treatment for Type 1 diabetes and insulin-dependent Type 2 diabetes. PharmaCyte plans to encapsulate a human cell line that has been genetically engineered to produce, store and release insulin in response to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box technology. Once the encapsulated cells are implanted in a diabetic patient they will function as a "bio-artificial pancreas" for purposes of insulin production.



FDA Grants Orphan Drug Designation to Pharmacyte Biotech for Pancreatic Cancer Treatment

European Medicines Agency (EMA), the European Commission has granted the Orphan Drug designation to PharmaCyte’s subsidiary,
PharmaCyte Biotech Europe Limited, for PharmaCyte’s pancreatic cancer treatment

 Company Address
PharmaCyte Biotech, Inc.

23046 Avenida de la Carlota, Suite 600
Laguna Hills, California 92652
Office Number: 917.595.2850
Facsimile Number: 917.595.2851

Market Value:
$122,386,272 a/o Dec 19, 2016

Shares Outstanding:
848,904,665 a/o Aug 29, 2016

Authorized Shares:
1,490,000,000 a/o Aug 26, 2014

817,204,665 a/o Aug 29, 2016

For more updated information please visit:

Transfer Agent:
Signature  Stock Transfer Inc. Plano TX  Ph # 972-612-4120

Investor Relations

Stonegate Capital Inc.
8201 Preston Road
Suite 325
Dallas, TX 75225
United States


   All News Releases:


What is Cell-in-a-Box®?

The Cell-in-a-Box® technology, developed by Austrianova, is a means to protect, isolate, storeand transport living cells. The proprietary technology can be used for a variety of purposes.
In healthcare, it facilitates the safe implantation of cells, holding them isolated from the immune system and allowing long term production of therapeutic molecules in patients. 
In biotechnology, the Cell-in-a-Box® technology protects cells in bioreactors and fermenters, while at the same time simplifying purification of bioproducts produced from the cells and reducing production cost. 
The technology can also be applied to probiotics, cosmetics and agriculture, environmental protection and monitoring, as well as forming the basis of a powerful research tool. 
The company’s proprietary cell packaging material, Gel8, used for the Cell-in-a-Box® technology, is derived from a naturally occurring material and is thus harmless to the environment, biologically inert and has been shown to be safe in humans. 

Management Team:

Kenneth L. Waggoner, Chief Executive Officer and President

Gerald W. Crabtree, Ph.D. – Chief Operating Officer and Director

Carlos A. Trujillo – Chief Financial Officer and Director

Walter H. Gunzburg – Chief Scientific Officer

Dr. Matthias Lohr as Chairman of Scientific Advisory Board

Thomas Liquard - Chairman of the Audit Committe

  Dr. Eva Maria (Lilli) Brandtner – Director of Diabetes Program Development

Dr. Manuel Hidalgo, Scientific Advisory Board





-  The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
-  We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
-  There are no guarantees when buying or selling any security.



Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PMCB News: Current Report Filing (8-k) 10/10/2017 08:31:01 AM
PMCB News: Notice of Effectiveness (effect) 09/29/2017 06:01:57 AM
PMCB News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 09/28/2017 04:18:18 PM
PMCB News: Securities Registration Statement (simplified Form) (s-3) 09/13/2017 09:26:54 AM
PMCB News: Quarterly Report (10-q) 09/13/2017 06:06:08 AM
#78282  Sticky Note The letter is dated September 19, 2017, and $Pistol Pete$ 11/10/17 05:01:51 PM
#62231  Sticky Note in full/ #2/ 01-28-2017/ Keeping an Eye on mick 01/28/17 07:35:33 PM
#52881  Sticky Note Here is a very nice list of accomplishments... Peacefulwendy 09/28/16 11:17:44 AM
#78611   Bullshit its trading at the bottom. I’ve been frosr6 11/24/17 04:23:56 PM
#78610   Yes we are ;-) $Pistol Pete$ 11/24/17 04:00:33 PM
#78609   Heading to Lake Tahoe for the weekend. PMCB $Pistol Pete$ 11/24/17 03:59:00 PM
#78608   We're in the money! $$$$$$$ ed7777777 11/24/17 03:52:28 PM
#78607   good afternoon my friend $PMCB mick 11/24/17 01:18:08 PM
#78606   Did you change your mind ? ferenc 11/24/17 09:56:23 AM
#78604   $PMCB Can PharmaCyte Biotech, Inc. (OTCPK:PMCB) Go The $Pistol Pete$ 11/24/17 01:35:00 AM
#78603   It is trading at the bottom already and $Pistol Pete$ 11/23/17 10:00:17 PM
#78602   Just wanted to let those of you who Sobber 11/23/17 09:42:05 PM
#78601   Year end tax selling could be brutal. rcstock 11/23/17 08:59:05 PM
#78600   So what if fda accepts pmcb IND application efood125 11/23/17 02:44:50 PM
#78599   couldn't agree more with you... But on this thenewmixer 11/23/17 12:17:29 PM
#78598   The only regret I have is listening to DrJay522 11/23/17 10:36:13 AM
#78597   Don't do it just yet. You will regret JODI1 11/23/17 10:28:05 AM
#78596   425,000 shares for sale tomorrow! I’m out. DrJay522 11/23/17 08:40:30 AM
#78595   Thanks! tjclark0551 11/22/17 05:24:33 PM
#78594   Those charts have been and continue to be PINKribbon 11/22/17 05:10:00 PM
#78593   $PMCB Thanksgiving wishes from across the miles from $Pistol Pete$ 11/22/17 04:07:31 PM
#78592   $PMCB Pharmacyte Biotech Inc (PMCB) shares have seen $Pistol Pete$ 11/22/17 03:56:19 PM
#78591   $PMCB Daily and Weekly Chart $Pistol Pete$ 11/22/17 03:37:25 PM
#78590 list?...this is a game changer for .04....forget efood125 11/22/17 02:53:43 PM
#78589   Syzygenic 11/22/17 02:48:09 PM
#78587   History tells me your spot on. frosr6 11/22/17 10:46:46 AM
#78586   Right there with you. Happy Thanksgiving! Pmcbinv 11/22/17 10:33:51 AM
#78585   Or perhaps someone is trying to pump the takeyouhigher 11/22/17 10:27:22 AM
#78584   Great Post Musky , Thank YOU esusun 11/22/17 10:05:37 AM
#78582   A lawyer a CPA and a washed up concordia 11/22/17 09:53:25 AM
#78581   Well sad! Happy Thanksgiving You all.Go pmcb ferenc 11/22/17 09:41:24 AM
#78580   LOL Three business models and 20 years of concordia 11/22/17 09:37:22 AM
#78579   Obviously not a scam. PMCB is a oldmusky 11/22/17 09:36:59 AM
#78576   If it takes twenty years to build a Syzygenic 11/22/17 09:12:10 AM
#78575   Its been a lot longer then 5 years concordia 11/22/17 09:05:42 AM
#78574   if pmcb sucks so bad... seattlevulture 11/22/17 08:48:05 AM
#78573   With all this scam talk...I am wondering when efood125 11/22/17 08:22:44 AM
#78572   Investors, do your own DD...if this fits your Brian903 11/22/17 07:36:38 AM
#78570   How would anyone “know for a fact” when frosr6 11/22/17 03:42:15 AM
#78569   Pretty sad when the top pancreatic cancer research frosr6 11/22/17 03:40:17 AM
#78568   No they aren’t frosr6 11/22/17 03:31:45 AM
#78567   Prove it. Pmcb is a con. #truth frosr6 11/22/17 03:31:21 AM
#78566   November next year I’ll be reading the same frosr6 11/22/17 03:28:38 AM
#78565   I think it is still at Eurofins for $Pistol Pete$ 11/21/17 11:37:33 PM
#78564   Yes they do $Pistol Pete$ 11/21/17 11:11:09 PM
#78563   What cells to Eurofins Pete?!! There are no PINKribbon 11/21/17 08:17:35 PM
#78562   TJ, at the time of that FB pic PINKribbon 11/21/17 07:53:16 PM
#78561   KW is anticipating Eurofins will begin manufacturing the PINKribbon 11/21/17 07:45:57 PM
#78560   The original culture medium was ordered and delivered PINKribbon 11/21/17 07:42:41 PM
#78559   In the past 4 fiscal years since Shady concordia 11/21/17 07:37:01 PM
#78558   Cell banks are NOT completed. PINKribbon 11/21/17 07:09:01 PM
#78557   You should listen to the cc again. PINKribbon 11/21/17 07:05:36 PM
#78556   lets start another email campaign to PMCB IR thenewmixer 11/21/17 05:58:18 PM